GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,000 | -12.5% | 30 | -58.9% | 0.00% | -50.0% |
| Q4 2020 | $8,000 | -27.3% | 73 | -35.4% | 0.00% | -33.3% |
| Q3 2020 | $11,000 | -21.4% | 113 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $14,000 | +40.0% | 113 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $10,000 | -16.7% | 113 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | -20.0% | 113 | -11.7% | 0.00% | -25.0% |
| Q3 2019 | $15,000 | -48.3% | 128 | -23.8% | 0.00% | -42.9% |
| Q2 2019 | $29,000 | +3.6% | 168 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $28,000 | +75.0% | 168 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $16,000 | -75.0% | 168 | -54.6% | 0.00% | -69.2% |
| Q3 2018 | $64,000 | +14.3% | 370 | -7.5% | 0.01% | 0.0% |
| Q2 2018 | $56,000 | +24.4% | 400 | 0.0% | 0.01% | +30.0% |
| Q1 2018 | $45,000 | -15.1% | 400 | 0.0% | 0.01% | -23.1% |
| Q4 2017 | $53,000 | +65.6% | 400 | +27.0% | 0.01% | +62.5% |
| Q3 2017 | $32,000 | 0.0% | 315 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $32,000 | – | 315 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |